Caricamento...
Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1)
Clinical application of potent anthracycline anticancer drugs, especially doxorubicin (DOX), is limited by a toxic cardiac side effect that is not fully understood and preventive strategies are yet to be established. Studies in genetically modified mice have demonstrated that focal adhesion kinase (...
Salvato in:
| Pubblicato in: | J Mol Cell Cardiol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237309/ https://ncbi.nlm.nih.gov/pubmed/24342076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2013.12.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|